Initial Public Offering (IPO): Registration Statement (General Form) — Form S-1
Filing Table of Contents
Document/Exhibit Description Pages Size
1: S-1 Registration Statement (General Form) 164 809K
2: EX-2.1 Recapitalization Agreement 59 262K
3: EX-2.2 Amend No. 1 to Recapitalization Agt 5 22K
4: EX-3.1.1 Certificate of Incorporation 11 38K
5: EX-3.1.2 By Laws of Charles River Lab. Holdings 17 53K
6: EX-4.1 Warrant Agreement 54± 207K
7: EX-4.2 Investors' Agreement 47 161K
8: EX-5.1 Opinion of Davis Polk & Wardwell 2 13K
14: EX-10.10 Amended and Restated Distribution Agt 16 55K
15: EX-10.11 Supply Agt - Sierra Biomedical and Scientific Res. 4 26K
9: EX-10.3 Material Contract 132 443K
10: EX-10.4 Indenture Among Charles River and Trustee 128 618K
11: EX-10.5 Purchase Agreement -Cr and Dlj 33 153K
12: EX-10.7 Material Contract 16 46K
13: EX-10.8 Amended and Restated Spa 62 266K
16: EX-12.1 Computation of Ratio of Earnings to Fixed Chgs 1 10K
17: EX-12.2 Computation of Ratio of Total Pro Forma Debt 1 8K
18: EX-12.3 Computation of Ratio of Adjusted Ebitda 1 8K
19: EX-21.1 Subsidiaries 1 7K
20: EX-23.2.1 Consent of Independent Accountants 1 8K
21: EX-23.2.2 Consent of Independent Accountants 1 8K
22: EX-27.1 FDS for Charles River Laboratories 2± 14K
EX-27.1 — FDS for Charles River Laboratories
[Enlarge/Download Table]
<ARTICLE> 5
<LEGEND>
The schedule contains summary information extracted from the consolidated
statement of earnings for the nine months ended September 30, 1999 and the
consolidated balance sheet at September 30, 1999 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<CIK> 1100682
<NAME> CHARLES RIVER LABORATORIES HOLDINGS, INC.
<MULTIPLIER> 1,000
<PERIOD-TYPE> 12-MOS 12-MOS 12-MOS 9-MOS 9-MOS
<FISCAL-YEAR-END> DEC-28-1996 DEC-27-1997 DEC-26-1998 DEC-26-1998 DEC-25-1999
<PERIOD-END> DEC-28-1996 DEC-27-1997 DEC-26-1998 SEP-26-1998 SEP-25-1999
<CASH> 0 17,915 24,811 0 3,457
<SECURITIES> 0 0 0 0 0
<RECEIVABLES> 0 28,280 32,466 0 33,820
<ALLOWANCES> 0 688 898 0 854
<INVENTORY> 0 28,904 30,731 0 28,577
<CURRENT-ASSETS> 0 83,323 97,214 0 77,303
<PP&E> 0 76,889 82,690 0 79,349
<DEPRECIATION> 0 8,320 9,168 0 0
<TOTAL-ASSETS> 0 196,211 233,410 0 210,371
<CURRENT-LIABILITIES> 0 41,577 59,792 0 56,707
<BONDS> 0 0 0 0 0
<PREFERRED-MANDATORY> 0 0 0 0 0
<PREFERRED> 0 0 0 0 0
<COMMON> 0 1 1 0 1
<OTHER-SE> 0 17,836 17,836 0 17,836
<TOTAL-LIABILITY-AND-EQUITY> 0 196,211 233,410 0 210,371
<SALES> 155,604 170,713 193,301 145,519 161,096
<TOTAL-REVENUES> 155,604 170,713 193,301 145,519 161,096
<CGS> 97,777 111,460 122,547 91,041 97,230
<TOTAL-COSTS> 97,777 111,460 122,547 91,041 97,230
<OTHER-EXPENSES> 33,685 37,177 35,429 26,238 30,528
<LOSS-PROVISION> 0 0 0 0 0
<INTEREST-EXPENSE> 491 501 421 311 207
<INCOME-PRETAX> 15,245 15,340 23,378 18,459 19,952
<INCOME-TAX> 10,889 8,449 14,123 11,280 16,903
<INCOME-CONTINUING> 15,245 15,340 23,378 18,459 19,952
<DISCONTINUED> 0 0 0 0 0
<EXTRAORDINARY> 0 0 0 0 0
<CHANGES> 0 0 0 0 0
<NET-INCOME> 15,245 15,340 23,378 18,459 19,952
<EPS-BASIC> 0<F1> 0<F1> 0<F1> 0<F1> 0<F1>
<EPS-DILUTED> 0<F1> 0<F1> 0<F1> 0<F1> 0<F1>
<FN>
<F1>The Company's equity is not publicly stated.
</FN>
Dates Referenced Herein
| This ‘S-1’ Filing | | Date | | Other Filings |
|---|
| |  |
| | 12/9/99 | | None on these Dates |
| Filed on: | | 12/8/99 |
| | 9/30/99 |
| List all Filings |
↑Top
Filing Submission 0000950103-99-001056 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Fri., May 3, 2:15:47.1am ET 